Imuraya Group Company Limited operates within the Candy & other confectionery products sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Imuraya Group Company Limited with three other
bakery and confectionary companies in Asia:
Ismail Industries Limited
sales of 19.60 billion Pakistan Rupees [US$176.44 million]
GlaxoSmithKline Consumer Healthcare Limited
(39.86 billion Indian Rupees [US$623.88 million]
of which 100%
was Nutritionals), and
Nakamuraya Co., Ltd.
(41.90 billion Japanese Yen [US$376.69 million]
of which 71%
was Confectionery Business).
During the year ended March of 2017, sales at
Imuraya Group Company Limited were ¥42.00 billion (US$377.56 million).
increase of 8.7%
versus 2016, when the company's sales were ¥38.64 billion.
This was the fifth consecutive year of sales increases at Imuraya Group Company Limited
(and since 2012, sales have increased a total of 29%).
Sales of Distribution Business saw an increase
8.9% in 2017, from
¥33.85 billion to ¥36.87 billion.